DAY-6 BONE-MARROW (D6BM) PREDICTS FOR COMPLETE REMISSION (CR) IN ADULTS WITH ACUTE MYELOID-LEUKEMIA (AML)

被引：0
|
作者：
BENGER, A
MEYER, R
WALKER, I
WILSON, WEC
BRAIN, M
LEBER, B
MCBRIDE, J
NEAME, P
LEVINE, M
BROWMAN, GP
机构：
[1] HAMILTON CIV HOSP,HAMILTON,ON,CANADA
[2] MCMASTER UNIV,HAMILTON L8S 4L8,ONTARIO,CANADA
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A303 / A303
页数：1
相关论文
共 50 条
  • [31] TREATMENT OF ACUTE MYELOID-LEUKEMIA IN 1ST REMISSION CHEMOTHERAPY VERSUS BONE-MARROW TRANSPLANTATION
    DEWITTE, T
    DEPAUW, B
    HOLDRINET, R
    JANSSEN, J
    HAANEN, C
    NETHERLANDS JOURNAL OF MEDICINE, 1985, 28 (07): : 281 - 284
  • [32] SPONTANEOUS COMPLETE REMISSION OF CHRONIC MYELOID-LEUKEMIA FOLLOWING HEMATOLOGICAL RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    ALKAM, M
    BRADSTOCK, KF
    HUGHES, WG
    WATSON, N
    BOWYER, I
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1990, 20 (05): : 710 - 712
  • [33] ALLOGENEIC BONE-MARROW TRANSPLANTATION IS THE TREATMENT OF CHOICE IN YOUNG-PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN 1ST COMPLETE REMISSION
    REIFFERS, J
    STOPPA, AM
    RIGALHUGUET, F
    MICHALLET, M
    DUFOIR, T
    MARIT, G
    BLAISE, D
    ATTAL, M
    CORRONT, B
    CONYMAKHOUL, P
    GASTAUT, JA
    LAURENT, G
    BROUSTET, A
    HOLLARD, D
    PRIS, J
    MARANINCHI, D
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 571 - 571
  • [34] STIMULATORY EFFECTS OF 2 GROWTH-FACTORS ON BONE-MARROW CULTURES FROM PATIENTS WITH ACUTE MYELOID-LEUKEMIA AT DIAGNOSIS AND IN COMPLETE REMISSION
    MULLER, MR
    FOPP, M
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (11): : 1780 - 1781
  • [35] RESULTS OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ACUTE MYELOID-LEUKEMIA (AML) IN 1ST REMISSION - A PROSPECTIVE NATIONAL STUDY IN THE NETHERLANDS
    LOWENBERG, B
    DEGAST, GC
    VERDONCK, LF
    VANDERLELIE, J
    GOUDSMIT, R
    SIZOO, W
    HAGENBEEK, A
    VANPUTTEN, WLJ
    DEPLANQUE, MM
    ZWAAN, FE
    ACTA HAEMATOLOGICA, 1987, 78 : 204 - 204
  • [36] LOW-DOSE IL-2 DURING 6 MONTHS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE MYELOID-LEUKEMIA (AML)
    FALKENBURG, JHF
    HOOFTMANDENOTTER, A
    VANDERELSHOUT, M
    VANDERMAREL, A
    KLUINNELEMANS, JC
    SCHAAFSMA, MR
    FIBBE, WE
    BRANDELY, M
    WILLEMZE, R
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1119 - 1119
  • [37] DAY-4 BONE-MARROW ASPIRATE FOR PREDICTION OF RESISTANCE TO INDUCTION CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA
    ARCHIMBAUD, E
    TREILLERITOUET, D
    GUYOTAT, D
    VIALA, JJ
    FIERE, D
    LEUKEMIA RESEARCH, 1987, 11 (03) : 281 - 283
  • [38] INTENSIVE CHEMOTHERAPY VERSUS ALLOGENEIC BONE-MARROW TRANSPLANTATION IN 1ST-REMISSION ACUTE MYELOID-LEUKEMIA
    MAYER, RJ
    BONE MARROW TRANSPLANTATION, 1990, 6 : 48 - 51
  • [39] ALLOGENEIC BONE-MARROW TRANSPLANTATION VERSUS CHEMOTHERAPY IN 1ST-REMISSION ACUTE MYELOID-LEUKEMIA - REPLY
    ZANDER, AR
    KEATING, MJ
    DICKE, KH
    FREIREICH, EJ
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (07) : 980 - 981
  • [40] ETOPOSIDE, MELPHALAN, TOTAL-BODY IRRADIATION AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA IN 1ST COMPLETE REMISSION
    CRUMP, M
    COUTURE, F
    BRANDWEIN, J
    BAKER, MA
    SUTCLIFFE, SB
    KEATING, A
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 706 - 706
12345